Washington Research Foundation is a venture capital firm in Washington that focuses on investing in companies operating in life sciences and enabling technologies developing products arising from research. Founded 1981 in Seattle, Washington, United States, it invests in early stage ventures, late stage ventures, series B, series A, debt financing, and seed. Its portfolio companies include AbSci, A-Alpha Bio,Faraday Pharmaceuticals, and AAVogen. As of March 2020, Washington Research Foundation has made 52 investments. Their most recent investment was on September 24, 2019, when A-Alpha Bio raised $2.8M. Washington Research Foundation has had 11 exits., the most notable of which include Alder Biopharmaceuticals, Omeros, and CSATS.